We treated 47 patients with recurrent transitional cell carcinoma of the bladder with intravesical chemotherapy. Twenty milligrams of mitomycin C per treatment was introduced 7 days after transurethral resection (TUR) or diagnostic cystoscopy, and was repeated at 2-week intervals for five times foll
Lntravesical Instillation of Mitomycin C in the Prophylactic Treatment of Recurring Superficial Transitional Cell Carcinoma of the Bladder
โ Scribed by M. DEVONEC; R. BOUVIER; J. SARKISSIAN; O. BENDIMERAD; A. GELET; J. M. DUBERNARD
- Book ID
- 115193006
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- English
- Weight
- 330 KB
- Volume
- 55
- Category
- Article
- ISSN
- 1464-4096
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Mitomycin C was administered t o 21 patients with metastatic transitional cell carcinoma of the urinary bladder. O f these, 19 patients were evaluable. Objective response occurred in f o u r patients, or 21 %. Hemopoietic depression was common and was dose related. Nephrotoxicity related t o the dr
Sixty patients with superficial papillary bladder cancer, Stages Ta and T1, received chemoprophylactic treatment to prevent recurrences after the complete resection of the primary lesion. The prophylactic regimen consisted of endovesical instillations alternating doxorubicin and mitomycin C. The fir